Travere Therapeutics-THIOLA EC



Visit our virtual booth here:  

THIOLA EC® (tiopronin, delayed-release tablets) is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone. Learn more about THIOLA EC and contact a local representative at  

Social media

Contact details

Products & Services

Documents & Links